“The story isn’t broken — the price was just too far ahead of the cash flow.” That summary, from one mid-April 2026 sell-side note, captures the entire argument over ORCL stock price. Oracle is trading at $153.61, down roughly 24% year-to-date and a stunning 55% below its 52-week high of $345.72. We rate ORCL a Buy with a $264.47 average price target — but only for investors who can stomach the gap between today’s price and the multi-year cloud build-out it’s funding.
Why is ORCL stock down so sharply, when revenue and remaining performance obligations are at all-time highs? This ORCL stock price analysis walks through the Key Stock Data, the OpenAI / Stargate capex worry, the named analyst targets, and the bull-bear case for buying the dip.
| Metric | Value |
|---|---|
| Current Price | $153.61 |
| 52-Week Range | $121.24 – $345.72 |
| Market Cap | $471B |
| P/E Ratio (TTM) | 27.94x |
| EPS (TTM) | $5.65 |
| Analyst Consensus | Moderate Buy |
| Average Price Target | $264.47 |
| YTD Performance | -24% |
Table of Contents
- Key Takeaways on ORCL Stock
- What Is Oracle Corporation (ORCL)?
- Why Is ORCL Stock Down in 2026?
- ORCL Stock Recent Performance
- ORCL Valuation Analysis
- Bullish and Bearish Analyst Opinions on ORCL
- ORCL Analyst Price Targets and Consensus
- How to Trade ORCL via MEXC
- ORCL Stock FAQ
Key Takeaways on ORCL Stock
- Price & verdict: ORCL trades at $153.61 — Buy rating with a $264.47 average analyst target, implying ~72% upside.
- Why ORCL stock is down: Investors are pricing the capital-intensity of Oracle’s $14-16B Michigan data center for OpenAI and the broader Stargate commitments, plus uncertainty over near-term free-cash-flow conversion.
- Bull case stat: Remaining Performance Obligations (RPO) reached $523 billion — the largest in software history — anchored by multi-year OCI consumption contracts.
- Bear case stat: Capex is guiding to $35B+ in FY2026, compressing free cash flow even as revenue accelerates.
- Catalyst watch: June 2026 fiscal Q4 earnings, Fusion Agentic Apps GA milestones, OpenAI compute consumption ramp.
What Is Oracle Corporation (ORCL)?
Oracle Corporation is the world’s second-largest enterprise software company by revenue and the operator of Oracle Cloud Infrastructure (OCI), the fourth-largest hyperscale cloud after AWS, Azure, and Google Cloud. Headquartered in Austin, Texas, Oracle’s business spans three pillars: legacy database licenses, Fusion / NetSuite SaaS applications, and OCI — the GPU-and-CPU compute layer that has become the company’s growth engine.
Three structural shifts define the modern Oracle story. First, OCI has won landmark AI-training contracts including OpenAI, ByteDance, and a multi-cloud partnership with all three big U.S. hyperscalers. Second, Fusion Agentic Applications — Oracle’s generative-AI overlay across ERP, HCM, and CX — give the company a defensible enterprise-AI software stack alongside the infrastructure layer. Third, the database business has finally migrated to the cloud, with Oracle Database@AWS, @Azure, and @Google Cloud now generating measurable revenue.
Why Is ORCL Stock Down in 2026?
The reason ORCL stock is down in 2026 is not a demand problem — it’s a capital-intensity problem. Three specific concerns drove the selloff from the September 2025 high of $345.72 to today’s $153.61:
1. The OpenAI / Stargate capex shock. Oracle disclosed a $14-16 billion Michigan data center build-out for OpenAI, plus participation in the broader Stargate consortium with SoftBank. The market initially celebrated the contract as a validation of OCI’s AI positioning. Then sell-side models started incorporating the actual capex required to deliver it — pushing FY2026 capex guidance above $35 billion, well above prior consensus. Free cash flow temporarily inverts.
2. The hyperscaler-AI rotation. Investors who bought ORCL as the cleanest AI infrastructure pure-play rotated into NVIDIA stock and Microsoft stock after Q1 results showed both names continuing to grow at scale with stronger near-term operating margins. Oracle’s narrative — “trust us, the cash will come in 2027-2028” — became harder to defend at a 30x+ forward multiple.
3. Customer concentration risk. When a single contract represents a meaningful share of forward revenue and is funded by a still-private counterparty whose own commercial trajectory is uncertain, the risk premium expands. Bears at Rothschild & Co Redburn cut Oracle to Sell in early 2026 explicitly citing “the heavy debt and capital burden” tied to the OpenAI deal.
The selloff is not because the business is shrinking. Revenue is accelerating, RPO is at record highs, and Fusion Agentic Apps are ramping. The selloff is because the market is asking how Oracle finances $35B+ of capex without diluting equity, taking on more debt at higher rates, or compressing margins.
ORCL Stock Recent Performance
ORCL hit an all-time high of $345.72 in September 2025, when management guided to OCI revenue accelerating to triple-digit year-over-year growth. From there:
- Q4 2025: First downdraft as analysts modelled the actual capex for OpenAI’s contract. Stock fell to ~$220.
- January-February 2026: Q2 FY2026 earnings beat on revenue but missed on free cash flow. Stock dropped to ~$180.
- March 2026: Rothschild downgrade to Sell. ORCL traded into the $150s.
- April 2026: Stabilising near $150-$155 as long-only buyers note the 17x forward EBITDA multiple is the cheapest since pre-OCI scale-up.
The 55% drawdown from the 52-week high is severe — but it has come without any commensurate downgrade to FY2027 or FY2028 revenue expectations. The Street has cut FCF estimates, not topline.
ORCL Valuation Analysis
At $153.61, ORCL trades at 27.94x trailing earnings and roughly 21x forward earnings — well below its 5-year average forward multiple of ~24x and a meaningful discount to hyperscaler peers like Microsoft (28x forward) and Amazon (32x forward). On EV/EBITDA, ORCL screens at the cheapest level since 2022.
| Multiple | ORCL | Software / Cloud Peer Avg | Implied Discount |
|---|---|---|---|
| Forward P/E | 21.0x | 28.0x | -25% |
| EV / Revenue (FY26) | 7.1x | 9.0x | -21% |
| EV / EBITDA (FY26) | 14.5x | 20.0x | -28% |
| RPO / Market Cap | 1.11x | 0.55x | +102% |
The most striking data point in the table is the RPO-to-market-cap ratio. With $523B in remaining performance obligations against a $471B equity value, ORCL is now trading below the contractual revenue it has already booked. Even discounting the OpenAI obligation aggressively, the math implies the market is paying nothing for Oracle’s database business, Fusion SaaS, NetSuite, or any future OCI bookings beyond what’s already signed.
Bullish and Bearish Analyst Opinions on ORCL
| Reasons for the Decline (Bear) | Reasons the Drop Is Overdone (Bull) |
|---|---|
| FY2026 capex guiding above $35B; FCF compression | $523B RPO is the largest in software history |
| Single-customer (OpenAI) concentration risk | OCI growth running at triple-digit YoY in latest quarters |
| Heavy debt funding for Stargate / Michigan build-out | Fusion Agentic Apps now contributing meaningful AI-software ARR |
| Rotation into AWS / Azure peers with cleaner near-term margins | Database@AWS / @Azure / @Google revenue compounding triple-digit |
| Macro fear that hyperscaler capex enters a digestion phase | Forward P/E 21x — cheapest vs. cloud peers since 2022 |
ORCL Analyst Price Targets and Consensus
Wall Street consensus on ORCL sits at Moderate Buy with an average 12-month price target of $264.47, implying ~72% upside from the current $153.61. The dispersion is wider than usual — bulls see a structural AI-infrastructure winner trading at a database-era multiple; bears see a capex-heavy story that won’t generate cash for another two years.
- JPMorgan — Overweight, $250 price target. Calls Oracle “the most underestimated AI infrastructure name in mega-cap software.”
- Wedbush (Dan Ives) — Outperform, $240 price target. Argues OpenAI deal is “transformational” and FY2027 free cash flow inflection is in the price.
- Morgan Stanley — Equal-Weight, $200 price target. Constructive on RPO, cautious on capex digestion timing.
- Rothschild & Co Redburn — Sell, $130 price target. Cites OpenAI deal capital burden as untenable absent further debt issuance.
- Bank of America — Buy, $275 price target. Highlights Database@cloud as the most underappreciated growth lever.
The honest read on ORCL: this is a Buy for investors with a 24-36 month horizon who can sit through capex compression. It is not a Buy for traders who need the next quarter to be the catalyst — fiscal Q4 (June 2026) will likely confirm capex guidance is real, and the stock could test $140 before the FY2027 free cash flow inflection becomes visible. The 72% gap to consensus is not free money; it’s payment for waiting.
How to Trade ORCL via MEXC
You can trade ORCL as a tokenized stock 24/7 on MEXC — no U.S. brokerage account required, settled in USDT. The ORCL USDT exchange pair tracks Oracle’s price action and lets you go long or short outside NYSE hours, including during overnight reactions to OpenAI capex headlines, hyperscaler earnings, or macro-AI rotation news.
Tokenized ORCL is particularly useful for crypto-native traders looking to express a view on the AI infrastructure trade without leaving the USDT settlement layer. Big Oracle moves frequently happen pre-market on the back of Stargate or OpenAI news flow — tokenized trading captures those windows.
ORCL Stock FAQ
Why is ORCL stock down 24% year-to-date in 2026?
ORCL stock is down 24% YTD because investors are repricing the capital intensity of Oracle’s $14-16B Michigan data center for OpenAI and the broader Stargate commitments. FY2026 capex is guiding above $35B, which compresses near-term free cash flow even as revenue and RPO accelerate to record highs.
Is ORCL a good stock to buy at $153?
ORCL at $153 trades at 21x forward earnings — the cheapest cloud / software peer multiple. With $523B in RPO against a $471B market cap, the math implies the market is effectively paying nothing for Oracle’s database, SaaS, and future OCI bookings. Buy rating for 24-36 month investors. Not a Buy for short-term traders given near-term capex digestion.
What’s the bull case on Oracle?
The bull case rests on three pillars: $523B RPO already locked, Fusion Agentic Apps adding software ARR at high margins, and Database@AWS / @Azure / @Google compounding the legacy database franchise into the cloud era. JPMorgan ($250), Wedbush ($240), and Bank of America ($275) all see significant upside as FY2027 free cash flow inflects.
What’s the bear case on Oracle?
The bear case is capex and concentration. Rothschild & Co Redburn rates ORCL Sell with a $130 target, citing the heavy debt and capital burden tied to the OpenAI contract. If FY2027 free cash flow disappoints or OpenAI’s commercial trajectory falters, Oracle would face a re-rating to a value multiple.
What is the highest analyst price target on ORCL?
The highest published target on ORCL is Bank of America’s $275, premised on Database@cloud revenue continuing to compound at triple-digit rates and Fusion Agentic Apps becoming a meaningful software contributor by FY2028.
Disclaimer
This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell securities. Past performance does not guarantee future results. Investors should conduct thorough due diligence and consult qualified financial advisors before making investment decisions.
MEXC is a global cryptocurrency exchange committed to “MEXCmize Your Opportunities.” Serving over 40 million users across 170+ countries, MEXC offers access to more than 3,000 digital assets across spot and derivatives markets. Known for its high liquidity and broad selection of trending tokens, the platform is designed to support both new traders and experienced investors. MEXC also continues to enhance trading efficiency through innovations such as zero trading fees, while prioritizing a secure, user-friendly, and accessible trading experience. Select MEXC as Your 0-fee Gateway To Infinite Opportunities.